JENNIFER BROWN: Open Payments
NPI 1275882789 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 71 payments from 16 companies in 2025. Trend: 2023 $1,379 · 2024 $4,135 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $433 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $418 |
| E.R. Squibb & Sons, L.L.C. | 13 | $342 |
| Axsome Therapeutics, Inc. | 5 | $194 |
| Janssen Pharmaceuticals, Inc | 3 | $181 |
| Supernus Pharmaceuticals, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Lundbeck LLC | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, SPRAVATO, Qelbree, FANAPT, REXULTI.
Industry payments across TX — which companies pay providers there.
